Chintan Dave

Chintan Dave is an Assistant Professor of Pharmacy and Epidemiology at the Ernest Mario College of Pharmacy, Rutgers University. He also serves as Assistant Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) and Academic Director of the Rutgers Center for Health Outcomes, Policy, and Economics (HOPE). His expertise spans pharmacoepidemiology, health outcomes research, geriatrics, diabetes, and cardiovascular disease.

Education:

• PharmD, St. Louis College of Pharmacy (2012)
• PhD in Pharmacoepidemiology, University of Florida (2017)
• Postdoctoral training, Harvard Medical School (2019)

Research focuses on leveraging large observational databases to assess drug safety and efficacy, particularly in cardiometabolic and geriatric populations. He has led studies on SGLT2 inhibitors for diabetes, generic drug pricing, and anaphylaxis risks with intravenous iron formulations. His work emphasizes advanced statistical methods for confounding adjustment.

Current grants include an NHLBI R01 award (2023–2028) on multimorbidity in older adults and a JDRF grant (2022–2025) studying diabetic ketoacidosis in type 1 diabetes. He is Principal Investigator for both.

Labs/Teams: Active in PETS and HOPE, leading industry fellowship programs and collaborative research initiatives.